Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials

被引：116

作者：

Vetvicka, Vaclav ^{[1
]}

Vannucci, Luca ^{[2
]}

Sima, Petr ^{[2
]}

Richter, Josef ^{[3
]}

机构：

[1] Univ Louisville, Dept Pathol & Lab Med, Louisville, KY 40292 USA

[2] Inst Microbiol, Dept Immunol, Prague 14220, Czech Republic

[3] Zdravotni Ustav Sidlem Usti Nad Labem, Usti Nad Labem 40001, Czech Republic

来源：

MOLECULES | 2019年 / 24卷 / 07期

关键词：

glucan; drug; immunity; food; supplement; infection; mushrooms; PLEUROTUS-OSTREATUS; INNATE IMMUNITY; RESPIRATORY-INFECTIONS; OAT-BRAN; RESISTANCE; RESPONSES; MICE; NUTRITION; CYTOKINES; ANTITUMOR;

D O I：

10.3390/molecules24071251

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Glucans are part of a group of biologically active natural molecules and are steadily gaining strong attention not only as an important food supplement, but also as an immunostimulant and potential drug. This paper represents an up-to-date review of glucans (beta-1,3-glucans) and their role in various immune reactions and the treatment of cancer. With more than 80 clinical trials evaluating their biological effects, the question is not if glucans will move from food supplement to widely accepted drug, but how soon.

引用

页数：17

共 50 条

[1] USE OF LABORATORY TESTS IN CLINICAL DRUG TRIALS
BONATI, M
FRANZOSI, MG
GALLETTI, F
LATINI, R
TOGNONI, G
JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1981, 19 (08): : 569 - 570
[2] CLINICAL TRIALS OF β-GLUCAN: EXPERIENCE FROM THE CZECH REPUBLIC
Vetvicica, Vaclav
Richter, Josef
PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON POLYSACCHARIDES-GLYCOSCIENCE, 2014, : 54 - 55
[3] Oat beta-glucan as a dietary supplement for dogs
Ferreira, Livia Geraldi
Endrighi, Mariangela
Lisenko, Karen Guttenkunst
Duarte de Oliveira, Maiara Rodrigues
Damasceno, Mateus Resende
Claudino, Jelieny Aparecida
Gutierres, Pamella Godinho
Peconick, Ana Paula
de Oliveira Borges Saad, Flavia Maria
Zangeronimo, Mimic Gilberto
PLOS ONE, 2018, 13 (07):
[4] Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials
Gershlick, AH
ATHEROSCLEROSIS, 2002, 160 (02) : 259 - 271
[5] CLINICAL LABORATORY TEST STANDARDS IN NEW DRUG TRIALS
HOLDEN, JMC
ITIL, T
SIMEON, J
FINK, M
JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS, 1967, 7 (01): : 1 - &
[6] Laboratory controlled trials are different from clinical trials
Betts, James A.
BRITISH MEDICAL JOURNAL, 2012, 345
[7] CLINICAL TRIALS OF β-GLUCAN: NEW BEGINNING
Vetvicka, Vaclav
Richter, Josef
Svozil, Vladimir
Dobiasova, Lucie Rajnohova
Kral, Vlastimil
PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON POLYSACCHARIDES-GLYCOSCIENCE, 2013, : 223 - 223
[8] Modeling laboratory data from clinical trials
Rosenkranz, Gerd K.
COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2009, 53 (03) : 812 - 819
[9] BRAF inhibitors: From the laboratory to clinical trials
Rahman, M. A.
Salajegheh, A.
Smith, R. A.
Lam, A. K. -Y.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 90 (03) : 220 - 232
[10] Beta Carotene: From biochemistry to clinical trials
Pryor, WA
Stahl, W
Rock, CL
NUTRITION REVIEWS, 2000, 58 (02) : 39 - 53

← 1 2 3 4 5 →